Table 2:

Association of lipid-lowering medication use and duration of use with incident prostate cancer, 6,518 men in ARIC (1990–2012)

	# Incident prostate cancers	Person-years	HR*	(95% CI)	HR†	(95% CI)
Current use
No	513	66,951	1	(Ref)	1	(Ref)
Yes	287	33,532	1.00	(0.86–1.18)	1.03	(0.87–1.21)
Duration of use
Never	513	66,951	1	Ref	1	Ref
<10 years	233	23,562	1.11	(0.94–1.31)	1.13	(0.95–1.34)
≥10years	54	9,970	0.67	(0.50–0.91)	0.68	(0.50–0.92)

^*Adjusted for age, and joint categories of race and field center.

^†Adjusted for age, joint categories of race and field center, height, updated BMI, updated cigarette smoking status, updated diabetes status, updated aspirin use, and education level.